FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1571940703> ?p ?o ?g. }

• W1571940703 endingPage "626" @default.
• W1571940703 startingPage "614" @default.
• W1571940703 abstract "Blockade of EGFR by EGFR tyrosine kinase inhibitors such as erlotinib is insufficient for effective treatment of human pancreatic cancer due to independent activation of the Akt pathway, while amiloride, a potassium-sparing diuretic, has been found as a potential Akt inhibitor. The aim of this study was to investigate the anticancer effects of combined amiloride with erlotinib against human pancreatic cancer cells in vitro.Cell proliferation, colony formation, cell cycle and apoptosis were analyzed in 4 human pancreatic cancer cell lines Bxpc-3, PANC-1, Aspc-1 and CFPAC-1 treated with erlotinib or amiloride alone, or in their combination. The synergistic analysis for the effects of combinations of amiloride and erlotinib was performed using Chou-Talalay's combination index isobolographic method.Amiloride (10, 30, and 100 μmol/L) concentration-dependently potentiated erlotinib-induced inhibition of cell proliferation and colony formation in the 4 pancreatic cancer cell lines. Isobolographic analysis confirmed that combinations of amiloride and erlotinib produced synergistic cytotoxic effects. Amiloride significantly potentiated erlotinib-induced G0/G1 cell-cycle arrest and apoptosis in Bxpc-3 and PANC-1 cells. Amiloride inhibited EGF-stimulated phorsphorylation of AKT, and significantly enhanced erlotinib-induced downregulation of phorsphorylation of EGFR, AKT, PI3K P85 and GSK 3β in Bxpc-3 and PANC-1 cells.Amiloride sensitizes human pancreatic cancer cells to erlotinib in vitro through inhibition of the PI3K/AKT signaling pathway. Treatment of pancreatic cancer patients with combination of erlotinib and amiloride merits further investigation." @default.
• W1571940703 created "2016-06-24" @default.
• W1571940703 creator A5014881178 @default.
• W1571940703 creator A5050828923 @default.
• W1571940703 creator A5051336977 @default.
• W1571940703 creator A5055968998 @default.
• W1571940703 creator A5056122667 @default.
• W1571940703 creator A5086281850 @default.
• W1571940703 creator A5086326013 @default.
• W1571940703 date "2015-04-13" @default.
• W1571940703 modified "2023-10-16" @default.
• W1571940703 title "Amiloride sensitizes human pancreatic cancer cells to erlotinib in vitro through inhibition of the PI3K/AKT signaling pathway" @default.
• W1571940703 cites W1483489765 @default.
• W1571940703 cites W1619850371 @default.
• W1571940703 cites W1931508686 @default.
• W1571940703 cites W1977748809 @default.
• W1571940703 cites W1989410548 @default.
• W1571940703 cites W2003867647 @default.
• W1571940703 cites W2015946454 @default.
• W1571940703 cites W2016710415 @default.
• W1571940703 cites W2018662643 @default.
• W1571940703 cites W2019240356 @default.
• W1571940703 cites W2042205913 @default.
• W1571940703 cites W2043527891 @default.
• W1571940703 cites W2049274590 @default.
• W1571940703 cites W2058822154 @default.
• W1571940703 cites W2061945098 @default.
• W1571940703 cites W2066082532 @default.
• W1571940703 cites W2074541871 @default.
• W1571940703 cites W2077945404 @default.
• W1571940703 cites W2095950160 @default.
• W1571940703 cites W2101465269 @default.
• W1571940703 cites W2101790304 @default.
• W1571940703 cites W2114197585 @default.
• W1571940703 cites W2124797061 @default.
• W1571940703 cites W2128059540 @default.
• W1571940703 cites W2135184154 @default.
• W1571940703 cites W2158134441 @default.
• W1571940703 cites W2161817637 @default.
• W1571940703 cites W2162121054 @default.
• W1571940703 cites W2164837623 @default.
• W1571940703 doi "https://doi.org/10.1038/aps.2015.4" @default.
• W1571940703 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4422948" @default.
• W1571940703 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25864651" @default.
• W1571940703 hasPublicationYear "2015" @default.
• W1571940703 type Work @default.
• W1571940703 sameAs 1571940703 @default.
• W1571940703 citedByCount "22" @default.
• W1571940703 countsByYear W15719407032016 @default.
• W1571940703 countsByYear W15719407032017 @default.
• W1571940703 countsByYear W15719407032018 @default.
• W1571940703 countsByYear W15719407032019 @default.
• W1571940703 countsByYear W15719407032020 @default.
• W1571940703 countsByYear W15719407032021 @default.
• W1571940703 countsByYear W15719407032022 @default.
• W1571940703 countsByYear W15719407032023 @default.
• W1571940703 crossrefType "journal-article" @default.
• W1571940703 hasAuthorship W1571940703A5014881178 @default.
• W1571940703 hasAuthorship W1571940703A5050828923 @default.
• W1571940703 hasAuthorship W1571940703A5051336977 @default.
• W1571940703 hasAuthorship W1571940703A5055968998 @default.
• W1571940703 hasAuthorship W1571940703A5056122667 @default.
• W1571940703 hasAuthorship W1571940703A5086281850 @default.
• W1571940703 hasAuthorship W1571940703A5086326013 @default.
• W1571940703 hasBestOaLocation W15719407031 @default.
• W1571940703 hasConcept C121608353 @default.
• W1571940703 hasConcept C126322002 @default.
• W1571940703 hasConcept C178790620 @default.
• W1571940703 hasConcept C185592680 @default.
• W1571940703 hasConcept C190283241 @default.
• W1571940703 hasConcept C2778087573 @default.
• W1571940703 hasConcept C2779438470 @default.
• W1571940703 hasConcept C2779608910 @default.
• W1571940703 hasConcept C2780210213 @default.
• W1571940703 hasConcept C2909325608 @default.
• W1571940703 hasConcept C502942594 @default.
• W1571940703 hasConcept C537181965 @default.
• W1571940703 hasConcept C55493867 @default.
• W1571940703 hasConcept C71924100 @default.
• W1571940703 hasConcept C75217442 @default.
• W1571940703 hasConcept C86554907 @default.
• W1571940703 hasConcept C98274493 @default.
• W1571940703 hasConceptScore W1571940703C121608353 @default.
• W1571940703 hasConceptScore W1571940703C126322002 @default.
• W1571940703 hasConceptScore W1571940703C178790620 @default.
• W1571940703 hasConceptScore W1571940703C185592680 @default.
• W1571940703 hasConceptScore W1571940703C190283241 @default.
• W1571940703 hasConceptScore W1571940703C2778087573 @default.
• W1571940703 hasConceptScore W1571940703C2779438470 @default.
• W1571940703 hasConceptScore W1571940703C2779608910 @default.
• W1571940703 hasConceptScore W1571940703C2780210213 @default.
• W1571940703 hasConceptScore W1571940703C2909325608 @default.
• W1571940703 hasConceptScore W1571940703C502942594 @default.
• W1571940703 hasConceptScore W1571940703C537181965 @default.
• W1571940703 hasConceptScore W1571940703C55493867 @default.
• W1571940703 hasConceptScore W1571940703C71924100 @default.
• W1571940703 hasConceptScore W1571940703C75217442 @default.
• W1571940703 hasConceptScore W1571940703C86554907 @default.

• next